ArticleBMC infectious diseases2026
HBV transmission from HBcAb-positive mothers: insights from pediatric liver transplantation studies.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
BACKGROUND &
aimsHepatitis B core antibody (HBcAb) is a marker of past or ongoing hepatitis B virus (HBV) infection and is frequently investigated in the context of occult HBV infection (OBI). While vertical transmission from mothers with OBI is recognized, the risk of transmission from mothers who are HBcAb-positive (HBsAg-negative) remains unclear. This study primarily aimed to directly assess the risk of HBV transmission from HBcAb-positive mothers to their children through the analysis of liver tissue samples. As an initial step, we characterized the prevalence of HBcAb in children born to these mothers.
methodsOur study employed a two-phase design. First, to establish the epidemiological context, we conducted a large-scale cross-sectional serological survey to determine the prevalence and decay kinetics of passively transferred maternal HBcAb in children. Second, to directly investigate the primary research question, we analyzed liver tissues from a distinct cohort of 49 pediatric transplant recipients (born to HBcAb-positive, HBsAg-negative mothers) retrieved from our institutional biobank. These samples were tested for intrahepatic HBV DNA using highly sensitive droplet digital PCR (ddPCR) and nested PCR.
resultsThe serological survey showed that passively acquired maternal HBcAb was present in 41.4% of newborns at birth and waned over several months. In the liver tissue analysis, intrahepatic HBV DNA was detected in 10 of the 49 pediatric transplant recipients (20.4%), providing direct evidence of occult infection.
conclusionOur findings suggest that vertical transmission from mothers who are HBcAb-positive but HBsAg-negative may represent a potential, underrecognized pathway for OBI in infants. These results underscore the need for further research to clarify the transmission risks associated with maternal HBcAb status to better inform prevention strategies in HBV high-endemicity regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.